Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2020-06-18–2026-03-27
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2020-06-18–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cardiff Oncology, Inc. (CRDF) | CEO | $635,000 | $3,023,344 |
| 2024 | Cardiff Oncology, Inc. (CRDF) | CEO | $610,584 | $2,401,376 |
| 2023 | Cardiff Oncology, Inc. (CRDF) | CEO | $594,400 | $1,547,772 |
| 2022 | Cardiff Oncology, Inc. (CRDF) | CEO | $570,600 | $1,590,347 |
| 2021 | Cardiff Oncology, Inc. (CRDF) | CEO | $532,716 | $3,635,198 |
| 2020 | Cardiff Oncology, Inc. (CRDF) | CEO | $444,764 | $1,150,703 |
| 2019 | Cardiff Oncology, Inc. (CRDF) | CSO | $398,729 | $852,951 |
| 2018 | Cardiff Oncology, Inc. (CRDF) | CSO | $387,155 | $908,524 |
Earnings-call appearances and filed executive appointments or departures, newest first.
